SULLIVAN LOUIS W 4

Accession 0001562180-24-008520

CIK 0001082554other

View on SEC.gov Company Profile

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 4:30 PM ET

Size

59.8 KB

Accession

0001562180-24-008520

Insider Transaction Report

Form 4

Period: 2024-12-18

UNITED THERAPEUTICS CorpUTHR

SULLIVAN LOUIS W

Director

Transactions

Exercise/Conversion
Common Stock
2024-12-18$175.43/sh+15,000$2,631,450→ 31,260 total
Sale
Common Stock
2024-12-18$366.11/sh−1,121$410,407→ 30,139 total
Sale
Common Stock
2024-12-18$366.97/sh−600$220,184→ 29,539 total
Sale
Common Stock
2024-12-18$374.14/sh−2,451$917,008→ 20,580 total
Sale
Common Stock
2024-12-18$380.12/sh−700$266,084→ 16,980 total
Sale
Common Stock
2024-12-18$381.41/sh−620$236,475→ 16,360 total
Sale
Common Stock
2024-12-18$368.67/sh−752$277,238→ 15,508 total
Sale
Common Stock
2024-12-18$370.02/sh−1,926$712,649→ 13,582 total
Sale
Common Stock
2024-12-18$368.50/sh−1,307$481,632→ 28,232 total
Sale
Common Stock
2024-12-18$382.63/sh−100$38,263→ 16,260 total
Sale
Common Stock
2024-12-18$379.67/sh−944$358,412→ 5,951 total
Sale
Common Stock
2024-12-18$370.30/sh−1,400$518,413→ 24,732 total
Sale
Common Stock
2024-12-18$375.00/sh−2,200$825,007→ 18,380 total
Sale
Common Stock
2024-12-18$381.37/sh−800$305,099→ 5,151 total
Sale
Common Stock
2024-12-18$369.32/sh−2,100$775,563→ 26,132 total
Sale
Common Stock
2024-12-18$373.12/sh−1,501$560,048→ 23,231 total
Sale
Common Stock
2024-12-18$374.46/sh−500$187,228→ 17,880 total
Sale
Common Stock
2024-12-18$379.30/sh−200$75,860→ 17,680 total
Sale
Common Stock
2024-12-18$371.25/sh−200$74,249→ 23,031 total
Sale
Common Stock
2024-12-18$373.06/sh−1,525$568,914→ 11,957 total
Sale
Common Stock
2024-12-18$375.03/sh−2,700$1,012,581→ 7,295 total
Sale
Common Stock
2024-12-18$377.46/sh−400$150,984→ 6,895 total
Sale
Common Stock
2024-12-18$382.25/sh−100$38,225→ 5,051 total
Sale
Common Stock
2024-12-18$370.78/sh−100$37,078→ 13,482 total
Sale
Common Stock
2024-12-18$374.17/sh−1,962$734,115→ 9,995 total
Gift
Common Stock
2024-12-19−1,851→ 3,200 total
Exercise/Conversion
Stock Options
2024-12-18−15,000→ 0 total
Exercise: $175.43From: 2016-06-26Exp: 2025-06-26→ Common Stock (15,000 underlying)

Holdings

Stock Options
(indirect: By Trust)
Exercise: $183.98From: 2022-07-08Exp: 2031-07-08→ Common Stock (3,230 underlying)
3,230
Stock Options
(indirect: By Trust)
Exercise: $336.37From: 2025-07-25Exp: 2034-07-25→ Common Stock (1,440 underlying)
1,440
Stock Options
(indirect: By Trust)
Exercise: $240.20From: 2023-07-07Exp: 2032-07-07→ Common Stock (2,490 underlying)
2,490
Stock Options
(indirect: By Trust)
Exercise: $229.81From: 2024-07-13Exp: 2033-07-13→ Common Stock (4,560 underlying)
4,560
Restricted Stock Unit
(indirect: By Trust)
Exercise: $0.00From: 2025-07-25→ Common Stock (590 underlying)
590

Footnotes (21)

[F1]This transaction was executed in multiple trades at prices ranging from $365.475 to $366.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F10]This transaction was executed in multiple trades at prices ranging from $378.91 to $379.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F11]This transaction was executed in multiple trades at prices ranging from $380.10 to $380.135. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F12]This transaction was executed in multiple trades at prices ranging from $381.205 to $381.645. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F13]This transaction was executed in multiple trades at prices ranging from $368.49 to $369.355. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F14]This transaction was executed in multiple trades at prices ranging from $369.49 to $370.475. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F15]This transaction was executed in multiple trades at prices ranging from $372.55 to $373.395. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F16]This transaction was executed in multiple trades at prices ranging from $373.70 to $374.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F17]This transaction was executed in multiple trades at prices ranging from $374.83 to $375.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F18]This transaction was executed in multiple trades at prices ranging from $379.36 to $380.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F19]This transaction was executed in multiple trades at prices ranging from $380.88 to $381.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F2]This transaction was executed in multiple trades at prices ranging from $366.545 to $367.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F20]Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
[F21]Not applicable as restricted stock units do not have an expiration date.
[F3]This transaction was executed in multiple trades at prices ranging from $367.87 to $368.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F4]This transaction was executed in multiple trades at prices ranging from $368.90 to $369.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F5]This transaction was executed in multiple trades at prices ranging from $369.95 to $370.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F6]This transaction was executed in multiple trades at prices ranging from $372.52 to $373.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F7]This transaction was executed in multiple trades at prices ranging from $373.70 to $374.585. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F8]This transaction was executed in multiple trades at prices ranging from $374.82 to $375.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F9]This transaction was executed in multiple trades at prices ranging from $377.16 to $378.065. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

UNITED THERAPEUTICS Corp

CIK 0001082554

→

Entity typeother

Related Parties

filerCIK 0001193522

Filing Metadata

Form type: 4
Filed: Dec 18, 7:00 PM ET
Accepted: Dec 19, 4:30 PM ET
Size: 59.8 KB

View on SEC.gov